Biopsy-site-marker in Breast Cancer

Part of paid clinical trials in Oklahoma City, Oklahoma.

Sponsor
University of Oklahoma
Study ID
NCT07833566
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Biopsy-Site Marker Placement. — DEVICE
    Tissue samples will be collected from Breast Cancer patients, stages I-III, who underwent lumpectomy (mastectomy) after biopsy site marker placement during image-guided biopsy.

Study Details

The purpose of this study is to explore pro-metastatic changes in breast cancer (BC) associated with the stiffness of biopsy site markers. This study aims to determine whether the stiffness of a biopsy site marker promotes inflammatory changes in breast cancer and to evaluate whether there is a relationship between biopsy site marker stiffness and inflammation.

Key Dates

First listed
Sep 22, 2026
Start date
Jul 9, 2026
Status verified
Sep 2026
Primary completion
Jul 31, 2028
Completion
Jul 31, 2030

Study Design

Enrollment
140 participants (estimated)

Arms

  • Arm: Breast Cancer Patients
    140 patients will be assigned to this group.

Primary Outcome Measure

Proportion of Patients With Evaluable Tissue Samples. [ Time Frame: 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
OU Health Stephenson Cancer CenterOklahoma CityOklahoma73117
Takemi Tanaka, PhD
[email protected]

Find similar trials in Oklahoma City, OK

Nationwide
Breast cancer trialsOncology trialsBreast oncology trialsWomen's health trials
By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
OU Health Stephenson Cancer Center· Oklahoma City, OK

Related Studies